4
Changes in Ownership
Merck & Co., Inc. Filed Acc 0001127602-22-025304
CEO & President sold 167,613 shares at an average $102.44 ($17,169,840)
- CEO & President acquired 167,613 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Davis Robert M · CEO & President
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-11-09 | Exercise or conversion : show line 1 in the form | +167,613 | 415,205.76 | D | ||
| 2022-11-09 | Sale : show line 2 in the form | −87,595 | $101.94 | $8,929,557 | 327,610.76 | D |
| 2022-11-09 | Sale : show line 3 in the form | −79,918 | $102.98 | $8,229,924 | 247,692.76 | D |
| 2022-11-09 | Sale : show line 4 in the form | −100 | $103.59 | $10,359 | 247,592.76 | D |
| Open-market sales · 167,613 sh · avg $102.44 · $17,169,840 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-09 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −167,613 | 0 | D |
Loading xslF345X03/form4.xml…